🔗 Share this article

The top legal official in Texas Ken Paxton is suing the manufacturers of Tylenol, alleging the firms concealed safety concerns that the medication posed to pediatric cognitive development.

This legal action follows a month after Former President Trump publicized an unproven link between using Tylenol - alternatively called acetaminophen - throughout gestation and autism spectrum disorder in offspring.

Paxton is taking legal action against Johnson & Johnson, which previously sold the drug, the exclusive pain medication approved for expectant mothers, and the current manufacturer, which now manufacturers it.

In a declaration, he claimed they "misled consumers by profiting off of discomfort and pushing pills ignoring the potential hazards."

Kenvue asserts there is no credible evidence tying acetaminophen to autism spectrum disorder.

"These corporations lied for decades, intentionally threatening countless individuals to line their pockets," Paxton, from the Republican party, said.

Kenvue said in a statement that it was "seriously troubled by the spread of false claims on the safety of paracetamol and the potential impact that could have on the welfare of US mothers and children."

On its official site, the company also mentioned it had "regularly reviewed the relevant science and there is insufficient valid information that indicates a established connection between consuming paracetamol and autism."

Groups speaking for doctors and medical practitioners concur.

The leading OB-GYN organization has stated acetaminophen - the main ingredient in acetaminophen - is a restricted selection for pregnant women to treat discomfort and elevated temperature, which can create serious health risks if left untreated.

"In more than two decades of investigation on the use of paracetamol in pregnancy, not a single reputable study has definitively established that the usage of paracetamol in any stage of gestation leads to brain development issues in offspring," the organization commented.

This legal action mentions recent announcements from the previous government in claiming the drug is allegedly unsafe.

Recently, the former president caused concern from health experts when he advised pregnant women to "fight like hell" not to use Tylenol when sick.

The FDA then released a statement that doctors should contemplate reducing the usage of Tylenol, while also mentioning that "a causal relationship" between the medication and autism spectrum disorder in children has not been proven.

Health Secretary RFK Jr, who manages the FDA, had pledged in April to conduct "extensive scientific investigation" that would identify the cause of autism in a short period.

But authorities advised that discovering a unique factor of autism - believed by scientists to be the consequence of a complicated interplay of inherited and external influences - would not be simple.

Autism spectrum disorder is a form of enduring cognitive variation and disability that affects how persons perceive and interact with the surroundings, and is diagnosed using physician assessments.

In his court filing, the attorney general - a Trump ally who is running for federal office - claims Kenvue and Johnson & Johnson "willfully ignored and attempted to silence the science" around acetaminophen and autism.

The lawsuit aims to force the corporations "destroy any marketing or advertising" that asserts acetaminophen is safe for pregnant women.

This legal action parallels the grievances of a collection of mothers and fathers of minors with autism and attention deficit hyperactivity disorder who filed suit against the manufacturers of Tylenol in recently.

A federal judge threw out the lawsuit, declaring studies from the parents' expert witnesses was not conclusive.